Myeloid Leukemia | OMICS International | Internal Medicine Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Myeloid Leukemia

Chronic Myeloid Leukemia (CML) is a clonal myeloproliferative disorder characterized by proliferation of granulocytic elements at all stages of differentiation. Patients are often discovered incidentally when an elevated White Blood Cell count (WBC) is revealed by routine Full Blood Count (FBC) or when an enlarged spleen is revealed during an abdominal examination. Non-specific symptoms of tiredness, fatigue, and weight loss may occur long after the onset of the disease. Otologic manifestations have been reported in 15-40% of leukemia patients. Internal Medicine Open Access, an official journal of OMICS International publishes all the articles related to Chronic Myeloid Leukemia. The journal is subjecting all the received manuscripts to a strict peer review process. The articles published in the journal are Open Access i.e, freely accessible to readers all around the world. Internal Medicine Open Access is maintaining the quality of articles through its strict peer review process.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021